This Just in: Data from Phase 3 Trial for Familial Adenomatous Polyposis is Coming Early 2019
Source: Pixabay.com

This Just in: Data from Phase 3 Trial for Familial Adenomatous Polyposis is Coming Early 2019

Familial adenomatous polyposis (FAP) is a condition which causes extra tissue to form in various parts of the body such as the large intestine and gastrointestinal track. FAP affects about…

Continue Reading This Just in: Data from Phase 3 Trial for Familial Adenomatous Polyposis is Coming Early 2019
Experimental Treatment for Biliary Atresia Gets Orphan Drug Designation in the EU
Capri23auto / Pixabay

Experimental Treatment for Biliary Atresia Gets Orphan Drug Designation in the EU

According to a story from Market Screener, the drug developer Albireo Pharma, Inc., recently announced that its investigational product candidate A4250 has earned Orphan Drug designation from the European Commission.…

Continue Reading Experimental Treatment for Biliary Atresia Gets Orphan Drug Designation in the EU
Device Allows Monitoring of Lung Function at Home For Duchenne Muscular Dystrophy Patients
Myriams-Fotos / Pixabay

Device Allows Monitoring of Lung Function at Home For Duchenne Muscular Dystrophy Patients

According to a story from EurekAlert!, monitoring lung function is an important role of managing Duchenne muscular dystrophy and other diseases that can cause wasting of the respiratory muscles. Many…

Continue Reading Device Allows Monitoring of Lung Function at Home For Duchenne Muscular Dystrophy Patients
How Planning a Wedding Solved the Riddle of a Sister’s Mysterious Illness
Source: Pixabay.com

How Planning a Wedding Solved the Riddle of a Sister’s Mysterious Illness

The Heritage Florida Jewish News reported a story about one sister's journey to her Gaucher Disease diagnosis, thanks to her older sister's wedding prep. What is Gaucher Disease? Gaucher disease…

Continue Reading How Planning a Wedding Solved the Riddle of a Sister’s Mysterious Illness
New Open Data Portal Will Improve Neurofibromatosis Research
Free-Photos / Pixabay

New Open Data Portal Will Improve Neurofibromatosis Research

According to a story from EurekAlert!, a collaboration of Sage Bionetworks, The Children's Tumor Foundation (CTF), and the Neurofibromatosis Therapeutic Acceleration Program (NTAP) have announced the initiation of the very…

Continue Reading New Open Data Portal Will Improve Neurofibromatosis Research
Possible Treatment for Spinal Muscular Atrophy Gains PRIME Designation From the EMA
Belova59 / Pixabay

Possible Treatment for Spinal Muscular Atrophy Gains PRIME Designation From the EMA

According to a story from pm360online.com, the pharmaceutical company Roche recently announced that its investigational therapy risdiplam has awarded PRIME designation from the European Medicines Agency (EMA). The drug has…

Continue Reading Possible Treatment for Spinal Muscular Atrophy Gains PRIME Designation From the EMA